HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Korinna Jöhrens Selected Research

anetumab ravtansine

11/2020Favorable therapeutic response after anti-Mesothelin antibody-drug conjugate treatment requires high expression of Mesothelin in tumor cells.
1/2019Mesothelin as a target for cervical cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Korinna Jöhrens Research Topics

Disease

17Neoplasms (Cancer)
11/2021 - 10/2009
8Hodgkin Disease (Hodgkin's Disease)
06/2022 - 12/2005
6Squamous Cell Carcinoma of Head and Neck
07/2022 - 01/2018
6Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 12/2010
5Fibrosis (Cirrhosis)
11/2019 - 05/2014
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 10/2016
4Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2021 - 12/2005
4Carcinoma (Carcinomatosis)
04/2019 - 01/2016
4B-Cell Lymphoma (Lymphoma, B Cell)
12/2016 - 10/2009
3Neoplasm Metastasis (Metastasis)
02/2022 - 01/2013
3Microsatellite Instability
11/2021 - 01/2020
3Inflammation (Inflammations)
11/2019 - 05/2014
3Adenocarcinoma
01/2019 - 10/2016
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 01/2016
3Wounds and Injuries (Trauma)
03/2016 - 05/2013
2Prostatic Neoplasms (Prostate Cancer)
02/2022 - 01/2022
2Endometrial Neoplasms (Endometrial Cancer)
11/2021 - 07/2021
2Lung Neoplasms (Lung Cancer)
08/2021 - 02/2018
2Infections
02/2021 - 08/2014
2Non-alcoholic Fatty Liver Disease
11/2019 - 09/2018
2Melanoma (Melanoma, Malignant)
08/2019 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
04/2019 - 01/2019
2Lymphoma (Lymphomas)
07/2015 - 10/2014
2Multiple Myeloma
07/2015 - 10/2009
2Hematologic Neoplasms (Hematological Malignancy)
10/2014 - 07/2011
2Breast Neoplasms (Breast Cancer)
01/2013 - 07/2011
2Hairy Cell Leukemia
10/2009 - 08/2007
1Xerostomia
07/2022
1Deglutition Disorders (Dysphagia)
07/2022
1Malignant Mesothelioma
01/2020
1Body Weight (Weight, Body)
11/2019
1Hypertrophy
11/2019
1Weight Loss (Weight Reduction)
11/2019
1Splenomegaly
02/2019
1Leukocytosis (Pleocytosis)
02/2019
1Colitis
02/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1Mesothelioma
01/2019
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019
1Alcoholic Fatty Liver
09/2018
1Atherosclerosis
09/2018

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
02/2022 - 02/2006
6B7-H1 AntigenIBA
12/2021 - 01/2016
6Immune Checkpoint InhibitorsIBA
11/2021 - 01/2016
4Messenger RNA (mRNA)IBA
04/2019 - 05/2013
4Transcription Factors (Transcription Factor)IBA
10/2014 - 12/2005
3MesothelinIBA
11/2020 - 01/2019
3Cisplatin (Platino)FDA LinkGeneric
01/2019 - 12/2017
3ParaffinIBA
04/2017 - 01/2017
3CytokinesIBA
01/2017 - 10/2008
3Estrogen ReceptorsIBA
01/2017 - 01/2013
2Androgen Receptors (Androgen Receptor)IBA
02/2022 - 01/2022
2AntigensIBA
01/2022 - 05/2015
2Programmed Cell Death 1 ReceptorIBA
12/2021 - 11/2020
2Estrogen Receptor alphaIBA
11/2021 - 01/2017
2pembrolizumabIBA
11/2021 - 07/2021
2dostarlimabIBA
11/2021 - 07/2021
2Pyridinolcarbamate (P23)IBA
10/2021 - 04/2009
2RNA (Ribonucleic Acid)IBA
08/2021 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
08/2021 - 01/2017
2anetumab ravtansineIBA
11/2020 - 01/2019
2Membrane Glycoproteins (Membrane Glycoprotein)IBA
11/2020 - 01/2019
2PlatinumIBA
01/2018 - 01/2018
2GemcitabineFDA Link
12/2017 - 01/2017
2Interleukin-13IBA
01/2017 - 05/2013
2Interleukin-5 (Interleukin 5)IBA
01/2017 - 05/2013
2AntibodiesIBA
01/2016 - 07/2011
2Interferon Regulatory FactorsIBA
07/2015 - 10/2014
2Interferon-gamma (Interferon, gamma)IBA
04/2010 - 10/2009
1GlycogenIBA
07/2022
1MEF2 Transcription FactorsIBA
06/2022
1Blocking AntibodiesIBA
03/2022
1Hormones (Hormone)IBA
11/2021
1Anaplastic Lymphoma KinaseIBA
10/2021
1SofosbuvirIBA
02/2021
1Antiviral Agents (Antivirals)IBA
02/2021
1daclatasvirIBA
02/2021
1Immunoconjugates (Immunoconjugate)IBA
11/2020
1Dihydrotachysterol (AT 10)IBA
11/2019
1Glucose (Dextrose)FDA LinkGeneric
11/2019
1Biomarkers (Surrogate Marker)IBA
09/2019
1SteroidsIBA
02/2019
1Pharmaceutical PreparationsIBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1Prostaglandin-E SynthasesIBA
10/2018
1Dietary CholesterolIBA
09/2018
1Soybean OilFDA LinkGeneric
09/2018
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
09/2018
1CholesterolIBA
09/2018
1Small Interfering RNA (siRNA)IBA
01/2018
1Indicators and Reagents (Reagents)IBA
01/2018

Therapy/Procedure

12Therapeutics
03/2022 - 07/2011
4Drug Therapy (Chemotherapy)
06/2022 - 07/2011
3Immunotherapy
12/2021 - 10/2016
2Radiotherapy
06/2022 - 03/2016
1Chemoradiotherapy
07/2022
1Castration
02/2022
1Aftercare (After-Treatment)
02/2021
1Cell Transplantation
01/2021